Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus

Systematic review: patient-reported outcomes in chronic hepatitis C - the impact of liver disease and new treatment regimens

(2015) Z. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

(2015) Zobair M. Younossi et al.   HEPATOLOGY

Improvement of health-related quality of life and work productivity in chronic hepatitis C patients with early and advanced fibrosis treated with ledipasvir and sofosbuvir

(2015) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes

(2015) Zobair M. Younossi et al.   JOURNAL OF INFECTIOUS DISEASES

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

(2015) Z. Younossi et al.   JOURNAL OF VIRAL HEPATITIS

The impact of ledipasvir/sofosbuvir on patient-reported outcomes in cirrhotic patients with chronic hepatitis C: the SIRIUS study

(2015) Zobair M. Younossi et al.   LIVER INTERNATIONAL

Costs and absence of HCV-infected employees by disease stage

(2015) Robert W. Baran et al.   JOURNAL OF MEDICAL ECONOMICS

The impact of hepatitis C burden: an evidence-based approach

(2014) Z. M. Younossi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The impact of the new antiviral regimens on patient reported outcomes and health economics of patients with chronic hepatitis C

(2014) Zobair Younossi et al.   DIGESTIVE AND LIVER DISEASE

Natural history of hepatitis C

(2014) Rachel H. Westbrook et al.   JOURNAL OF HEPATOLOGY

Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study

(2014) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection

(2014) Nezam Afdhal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3

(2014) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis

(2014) Kris V. Kowdley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)

(2013) Zobair M. Younossi et al.   JOURNAL OF HEPATOLOGY

Epidemiology and natural history of HCV infection

(2013) Behzad Hajarizadeh et al.   Nature Reviews Gastroenterology & Hepatology

Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options

(2013) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection

(2013) Eric Lawitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

The high comorbidity burden of the hepatitis C virus infected population in the United States

(2012) Karly S Louie et al.   BMC INFECTIOUS DISEASES

The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities

(2011) Marco daCosta DiBonaventura et al.   JOURNAL OF MEDICAL ECONOMICS

The impact of hepatitis C virus infection on work absence, productivity, and healthcare benefit costs

(2010) Jun Su et al.   HEPATOLOGY

Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C

(2009) Ava A John-Baptiste et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Understanding work productivity and its application to work-related musculoskeletal disorders

(2007) Reuben Escorpizo   INTERNATIONAL JOURNAL OF INDUSTRIAL ERGONOMICS